Kyle Woodley

Kyle Woodley

Kyle Woodley is the Senior Investing Editor of Kiplinger.com. His articles covering stock picks, exchange-traded funds and mutual funds have been featured on MSN, Nasdaq and U.S. News & World Report. He also has appeared on Fox Business Network.

He previously was Managing Editor of InvestorPlace.com, and an award-winning designer and copy editor with Gannett. He also is a graduate of Ohio State University.

Kyle can be reached at kwoodley@kiplinger.com, or you can follow him on Twitter at @KyleWoodley.

Recent Articles

Discover Financial Keeps Surprising

It's already up nearly 40% this year -- to all-time highs -- and the future still looks good. A one-two punch of value and growth is tough to beat.

Amylin Perks Up on Rejection — Wednesday’s IP Market Recap

A spurned bid from Bristol-Myers Squibb sends AMLN up 54% on speculation that other offers will roll in.

The Triumphs (and Troubles) of Trebles

3x leveraged ETFs have put up some big numbers so far, for better or for worse -- and they also tell a pretty accurate tale of 2012's first quarter.

New Apple High Amid the Dips — Tuesday’s IP Market Recap

While the major indexes slipped back after Monday's jump, Apple set yet another record.

Are These 3 ‘Comeback Stocks’ for Real?

Everyone loves a comeback, but before investing in these rallying stocks, consider some of these facts.

The Dow Dazzles — Monday’s IP Market Recap

Fed Chairman Ben Bernanke provided some soothing comments about interest rates, and stocks soared.

Plenty of Flavor in Tiny Batch of New ETFs

Among a small batch of new ETFs launched last week are a 'fair and balanced' Nasdaq 100 and a leveraged play on real estate.

Under Armour’s Game Plan Is Playing Out Well

It's growing wildly -- and very profitably. The future also looks quite promising. But, oh, that pricey stock. Still, here's why UA could help your team.

McDonald’s CEO Skinner Stepping Down

McDonald's CEO Jim Skinner, who helmed MCD shares to 300% gains since late 2004, is stepping down, leaving the company to Don Thompson.

GMCR, Watson Zoom on Deals — Wednesday’s IP Market Recap

Green Mountain gets a much-needed lift from Starbucks, and Watson is buying generic-drug maker Actavis.